Pang Hao H - OmicsDI

Show results for

Unknown (107)
Transcriptomics (5)
Proteomics (5)
Metabolomics (3)

Organisms

Mus musculus (6)
Homo sapiens (2)
Vibrio parahaemolyticus RIMD 2210633 (1)
Alphavirus (1)
Betaherpesvirinae (1)
Brassica oleracea var. oleracea (1)
Cowpox virus (1)
Coxsackievirus (1)
Cytomegalovirus (1)
Dengue virus (1)
EFO:0001352 (1)
Filoviridae (1)
Hepatitis B virus (1)
Human alphaherpesvirus 1 (1)
Human betaherpesvirus 5 (1)
Human immunodeficiency virus (1)
Human immunodeficiency virus 1 (1)
Human immunodeficiency virus 2 (1)
Influenza A virus (1)
Influenza C virus (1)
Japanese encephalitis virus (1)
Japanese encephalitis virus group (1)
Lyssavirus rabies (1)
Monkeypox virus (1)
Nostoc sp. PCC 7120 = FACHB-418 (1)
Oropouche virus (1)
Orthopoxvirus (1)
Orthopoxvirus vaccinia (1)
Rattus (1)
Ruditapes decussatus (1)

Repository

biostudies-arrayexpress (5)
iProX (4)
MetaboLights (3)
pride (1)

Disease

Breast cancer (1)

Technology Type

Mass spectrometry (3)
Mass Spectrometry (1)
SWATH MS (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (2)
Illumina NovaSeq X (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - positive (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2015 (3)
2022 (2)
2026 (1)
2009 (1)
2025 (1)
2023 (1)
2021 (1)
2020 (1)

CHEBI ID

CHEBI:190234 (1)
CHEBI:190232 (1)
CHEBI:190231 (1)
CHEBI:190230 (1)
CHEBI:88496 (1)
CHEBI:190228 (1)
CHEBI:89679 (1)
CHEBI:190225 (1)
CHEBI:90458 (1)
CHEBI:190223 (1)
CHEBI:137127 (1)
CHEBI:186031 (1)
CHEBI:190218 (1)
CHEBI:88513 (1)
CHEBI:90491 (1)
CHEBI:89264 (1)
CHEBI:190212 (1)
CHEBI:190208 (1)
CHEBI:190205 (1)
CHEBI:190201 (1)
CHEBI:190199 (1)
CHEBI:190197 (1)
CHEBI:134503 (1)
CHEBI:89373 (1)
CHEBI:190193 (1)
CHEBI:190191 (1)
CHEBI:186875 (1)
CHEBI:186736 (1)
CHEBI:187564 (1)
CHEBI:190241 (1)

Metabolite Name

Glycohyodeoxycholic acid (1)
PC(41:2p) (1)
SM(d45:1)(rep) (1)
SM(d46:4) (1)
PE(18:0p/22:1) (1)
SM(d43:1) (1)
CerG1(d42:1) (1)
Cer(d42:4) (1)
SM(d42:0)(rep) (1)
SM(d44:2)(rep) (1)
SM(d43:3)(rep)(rep) (1)
CerG2(d18:1/24:0) (1)
PE(18:1/21:0) (1)
PE(18:0p/20:1) (1)
PE(18:0p/20:1)(rep) (1)
SM(d41:1)(rep) (1)
SM(d45:5) (1)
SM(d40:0)(rep) (1)
PE(22:0/20:3) (1)
CerG1(d18:1/24:1) (1)
CerG1(d42:2) (1)
CerG1(d18:1/22:1) (1)
SM(d44:3) (1)
SM(d18:1/24:3) (1)
PE(18:2/21:0) (1)
PC(34:2p)(rep) (1)
DMePE(36:2p) (1)
PE(18:1p/20:1)(rep) (1)
CerG2(d42:2) (1)
PE(18:0p/18:1) (1)

Study type

Transcription profiling by array (2)
RNA-seq of coding RNA (2)
RNA-seq of coding RNA from single cells (1)

Release Date

2022 (21)
2023 (17)
2024 (15)
2025 (11)
2021 (10)
2015 (8)
2020 (7)
2026 (6)
2019 (5)
2018 (4)
2016 (2)
2013 (2)
2009 (1)
2014 (1)
2012 (1)
2011 (1)

Lab affiliation

Harbin Medical University (1)

Previous page
1 / 12
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 12
Next page

Sort by:

Relevance

Page size

Lung Lipidomic Alterations in Beagle Dogs Infected with Toxocara canis

Toxocariasis, mainly caused by Toxocara canis, and to a lesser extent, Toxocara cati, is a neglected parasitic zoonosis. The mechanisms that underlie the changes in lipid metabolism of T. canis infection in Beagle dogs' lungs remain unclear. Lipidomics is a rapidly emer...

2023-08-21 | MTBLS5583 | MetaboLights

iTRAQ in proteomic analysis of potential biomarkers in invasive cancer, ductal carcinoma in situ, and mammary fibroadenoma

Breast malignancy is a serious threat to women’s health around the world. However, for invasive, ductal carcinomas, and mammary fibroadenoma, there is an urgent demand for better breast malignancy-linked biomarkers. The current study was designed to identify diagnostic and/or therapeutic protein bio...

ORGANISM(S): Homo sapiens (Human)

2020-10-13 | PXD019963 | Pride